Membrane Chromatography

Membrane Chromatography

Global Membrane Chromatography Market to Reach US$1.0 Billion by 2030

The global market for Membrane Chromatography estimated at US$395.9 Million in the year 2023, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 14.2% over the analysis period 2023-2030. Ion Exchange Technique, one of the segments analyzed in the report, is expected to record a 14.1% CAGR and reach US$492.2 Million by the end of the analysis period. Growth in the Affinity Technique segment is estimated at 15.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$102.2 Million While China is Forecast to Grow at 18.5% CAGR

The Membrane Chromatography market in the U.S. is estimated at US$102.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$252.1 Million by the year 2030 trailing a CAGR of 18.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.6% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.6% CAGR.

Global Membrane Chromatography Market - Key Trends and Drivers Summarized

Why Is Membrane Chromatography Gaining Popularity in Bioprocessing?

Membrane chromatography is increasingly becoming a vital component in the bioprocessing sector, primarily due to its ability to streamline purification processes in the production of biopharmaceuticals. Unlike traditional column chromatography, membrane chromatography offers faster processing times and higher throughput, making it ideal for large-scale biomanufacturing. This technique involves the use of membranes with specific ligand interactions that capture target molecules, such as proteins or viruses, from a mixture, allowing for efficient purification. Its growing importance is linked to the rise in demand for monoclonal antibodies, vaccines, and gene therapies, all of which require high levels of purification.

What Are the Key Innovations in Membrane Chromatography?

Recent innovations in membrane chromatography include the development of high-capacity and high-flow membranes that reduce processing time while increasing efficiency. The latest generation of membrane adsorbers, which are capable of handling large volumes, are designed to provide superior binding capacities and minimize the risk of fouling. Additionally, advancements in ligand chemistry have led to more selective membranes, capable of isolating specific biomolecules with higher purity levels. Single-use membrane chromatography systems are also becoming more common, offering cost-effectiveness and eliminating the need for cleaning and validation between batches, making them highly appealing in the biopharmaceutical industry.

How Do Market Segments Define the Growth of Membrane Chromatography?

Product types include ion exchange membranes, affinity membranes, and hydrophobic interaction membranes, with ion exchange membranes holding the largest market share due to their wide applicability in protein purification. Operation modes include flow-through and bind-and-elute, with the flow-through mode gaining popularity for its efficiency in removing impurities during downstream processing. End-users of membrane chromatography systems include biopharmaceutical companies, research institutes, and contract research organizations (CROs), with biopharmaceutical companies being the dominant segment due to the rising production of biologics.

What Factors Are Driving the Growth in the Membrane Chromatography Market?

The growth in the membrane chromatography market is driven by several factors, including the increasing demand for biologics and biosimilars, advancements in bioprocessing technologies, and the rising focus on single-use technologies in manufacturing. Biopharmaceutical companies are under pressure to develop faster, more efficient purification methods, and membrane chromatography offers a viable solution. The growing trend towards continuous manufacturing and the use of single-use systems in bioprocessing is also contributing to the adoption of membrane chromatography. Furthermore, regulatory agencies are encouraging innovations that improve the efficiency and safety of biopharmaceutical production, further fueling market growth.

Select Competitors (Total 34 Featured) -

• 3M
• Asahi Kasei Corporation
• Cole-Parmer Instrument Company, LLC
• Danaher
• General Electric
• GL Sciences Inc.
• GVS Group
• Membrane Solutions
• Merck KGaA
• Purilogics LLC
• Restek Corporation
• Sartorius AG
• STARLABS
• Thermo Fisher Scientific Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.